Evotec to Present at the BIO CEO & Investor Conference 2008 in New
York
Corporate news announcement processed and transmitted by Hugin ASA.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------
Hamburg, Germany | Oxford, UK - Evotec AG (Frankfurt Stock Exchange:
EVT) today announced that Jörn Aldag, President & CEO, will present
at the BIO CEO & Investor Conference in New York.
Date: Tuesday, 12 February 2008
Time: 11.45 am EST (05.45 pm CET/04.45 pm GMT)
Location: Waldorf-Astoria, New York City
The presentation slides will be available on the Evotec website at
www.evotec.com - Investors shortly after the presentation.
Contact: Anne Hennecke, Senior Vice President, Investor Relations &
Corporate Communications, Evotec AG, Phone: +49-40-56081-286,
anne.hennecke@evotec.com
--- End of Message ---
Evotec AG
Schnackenburgallee 114 Hamburg Germany
WKN: 566480; ISIN:
DE0005664809 ; Index: Prime All Share, CDAX, HDAX, MIDCAP, TECH All
Share;
Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime
Standard in Frankfurter Wertpapierbörse,
Freiverkehr in Börse Berlin, Freiverkehr in Bayerische Börse München,
Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Niedersächsische Börse zu Hannover;
